6 Jul 2012 07:00

AIM: ODX
Â
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company)
Â
Grant of Options
Â
Â
Omega, the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that its Remuneration Committee on 5 July 2012 awarded the following director share options:
Â
Options granted 5 July 2012 | Total options following grant  | |||
Andrew Shepherd | 600,000 | 1,303,480 | ||
Kieron Harbinson | 300,000 | 768,987 | ||
Jag Grewal | 200,000 | 300,000 |
Â
All options are awarded under the Company's EMI Share Option Scheme. The options have a three year vesting period, have been awarded at an exercise price of 14.5p (closing mid market price on 4 July 2012) and after they are fully vested, there is a performance criteria that they cannot be exercised until the share price is at 25p or higher.
Â
Â
Contacts:Â
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Kieron Harbinson, Group Finance Director | www.omegadiagnostics.com |
Seymour Pierce Group | Tel: 020 7107 8000 www.seymourpierce.com |
Freddy Crossley / Mark Percy (Corporate Finance) David Banks / Katie Ratner (Corporate Broking) | |
Walbrook PR Limited | |
Paul McManus | Tel: 020 7933 8787 Mob: 07980 541 893 paul.mcmanus@walbrookpr.com  |
Paul Cornelius | Tel: 020 7933 8794 |
Mob: 07886 384 707 | |
paul.cornelius@walbrookpr.com |
Â